Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-05-23
2006-05-23
Nickol, Gary (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S389100, C530S388100
Reexamination Certificate
active
07049409
ABSTRACT:
The present invention relates to a novel HLF protein which is a member of the heregulin family. In particular, isolated nucleic acid molecules are provided encoding the human HLF protein. HLF polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of HLF activity. Also provided are diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation of cell growth.
REFERENCES:
patent: 6096871 (2000-08-01), Presta et al.
patent: 6121415 (2000-09-01), Godowski et al.
patent: 6252051 (2001-06-01), Godowski et al.
patent: WO-99/02681 (1999-01-01), None
Coligan et al. Current Protocols in Immunology, 1991, John Wiley & Sons, USA, pp. 2.1.2-2.1.22.
Hillier et al., “yn72d05.r1 Soares adult brain N2b5HB55Y Homo sapiens cDNA clone IMAGE:173961 5' similar to SP:A43273 A43273 Heregulin-Alpha Precursor -;contains LTR7 repetitive element ;, mRNA sequence,” Database EMBL ‘Online’ Accession No. H23651 (Jul. 8, 1995).
Lewis et al., “Growth Regulation of Human Breast and Ovarian Tumor Cells by Heregulin: Evidence for the Requirement of ErbB2 as a Critical Component in Mediating Heregulin Responsiveness,”Cancer Res., 56:1457-1465 (Mar. 1996).
Zhang et al., “Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4,”PNAS USA, 94:9562-9567 (Sep. 1997).
Holmes et al., “Identification of Hereguln, a Specific Activator of p185erbB2,”Science, 256:1205-1210 (May 22, 1992).
George et al., “Macromolecular Sequencing and Synthesis: Selected Methods and Application,” Schlesinger, D.H. (eds.), Alan R. Liss, Inc., New York, NY, pp. 127-149 (1988).
Wilson, R.K., “The WashU-Merck EST Project,” GenBank Accession No. H50042 (Sep. 18, 1995).
Wilson, R.K., “The WashU-Merck EST Project,” GenBank Accession No. H49100 (Sep. 18, 1995).
Wilson, R.K., “The WashU-Merck EST Project,” GenBank Accessoin No. H23651 (Jul. 6, 1995).
Culouscou et al., “Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/P180ERB4 receptor,”J. Biol. Chem., 268(25):18407-18410 (1993).
Garraway et al., “Neuregulin-2, a new ligand of Erb3/Erb4-receptor tyrosine kinase,”Nature, 387:512-516 (1997).
Gassmann et al. “Aberrant neural and cardiac development in mice lacking the ErB4 neuregulin receptor,”Nature, 378(6555):390-394 (1995).
Hijazi et al. “NRG-3 in human breast cancers: Activation of multiple erbB family proteins,”Int'l J. Oncology, 13(5):1061-1067 (1998).
Laverriere et al. “GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut,”J. Biol. Chem., 269(37):23177-23184 (1994).
Plumb et al., “Human DNA sequence from clone RP1-185K11,” Database EMBL ‘Online’ Accession No. AL136085 (Jan. 7, 2000).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerence to Amino Acid Substitutions,”Science, 247:1306-1310 (1990).
Lazar et al., “Transforming Growth Factor Alpha: Mutation Aspartic Acid 47 and Leuine 48 Results in Different Biological Activities,”Molec. and Cell. Biol., 8:1247-1252 (1988).
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue,”J. Cell. Biol., 111:2129-2138 (1990).
Bork, P., “Powers and pitfalls in sequence analysis,”Genome Res., 10:398-400 (2000).
Hijazi Mia
King C. Richter
Ruben Steven M.
Young Paul E.
Aeder Sean
Georgetown University Medical Center
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Nickol Gary
LandOfFree
Heregulin-like factor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heregulin-like factor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heregulin-like factor antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3591228